Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infusion of dexmedetomidine and magnesium sulfate on hemodynamic stability
IRCT20190325043107N46Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and magnesium sulfate in Cardiovascular collapse, sponsored by Tabriz University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
Cardiovascular collapse
Beyond the preview
Go deeper on IRCT20190325043107N46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N46.